โ† All deals

Twist Bioscience Corp

Public Equity (NASDAQ)B2BBiotechnologySynthetic DNA
๐Ÿ“ South San Francisco, CA, United Statesโ€ข Founded 2013
StreetZero Signal 62
Be the first to signal interest

About Twist Bioscience Corp

Twist Bioscience Corporation is a biotechnology company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform. It is a public company listed on NASDAQ under TWST and operates in the biotechnology research industry with a B2B business model. The company is headquartered in South San Francisco, California, and was founded in 2013.

LATEST FUNDINGRule 144
$1.8M
Announced 2026-11-19
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Twist Bioscience Corp.

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Completed $107.4M follow-on public offering of common stock in June 2020.
  • Public company on NASDAQ:TWST with multiple post-IPO equity raises including $250M rounds.
  • Develops high-quality synthetic DNA on a silicon platform for NGS, synbio, and biologics.
  • Headquartered in South San Francisco with 189k+ LinkedIn followers.
  • Uses offering proceeds for R&D, capacity expansion, and working capital.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account